Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-11-01 4:04 pm Purchase | 13G | CLEARSIDE BIOMEDICAL INC CLSD | WHITMORE BRADFORD T | 6,264,964 10.1% | 247,112 (+4.11%) | View |
2023-02-14 10:29 am Sale | 13G | CLEARSIDE BIOMEDICAL INC CLSD | RTW INVESTMENTS LP | 0 0% | -3,806,018 (Position Closed) | View |
2023-02-13 12:19 pm Sale | 13G | CLEARSIDE BIOMEDICAL INC CLSD | Carmignac Gestion | 2,400,344 3.98% | -723,908 (-23.17%) | View |
2023-01-04 4:15 pm Sale | 13D | CLEARSIDE BIOMEDICAL INC CLSD | Hatteras Venture Advisors III LLC | 3,654,062 6.1% | -1,360,858 (-27.14%) | View |
2023-01-04 12:06 pm Purchase | 13G | CLEARSIDE BIOMEDICAL INC CLSD | WHITMORE BRADFORD T | 6,017,852 9.9% | 139,655 (+2.38%) | View |
2022-02-14 08:44 am Sale | 13G | CLEARSIDE BIOMEDICAL INC CLSD | RTW INVESTMENTS LP | 3,806,018 6.4% | -152,112 (-3.84%) | View |
2022-02-09 2:09 pm Sale | 13G | CLEARSIDE BIOMEDICAL INC CLSD | Carmignac Gestion | 3,124,252 5.2% | -416,709 (-11.77%) | View |
2022-01-24 4:03 pm Sale | 13G | CLEARSIDE BIOMEDICAL INC CLSD | WHITMORE BRADFORD T | 5,878,197 9.9% | -486,989 (-7.65%) | View |
2021-02-12 12:25 pm Purchase | 13G | CLEARSIDE BIOMEDICAL INC CLSD | Carmignac Gestion | 3,540,961 7.3% | 3,540,961 (New Position) | View |
2021-02-12 09:55 am Purchase | 13G | CLEARSIDE BIOMEDICAL INC CLSD | RTW INVESTMENTS LP | 3,958,130 8.19% | 208,023 (+5.55%) | View |
2021-01-07 11:10 am Purchase | 13G | CLEARSIDE BIOMEDICAL INC CLSD | WHITMORE BRADFORD T | 6,365,186 11.1% | 929,845 (+17.11%) | View |
2020-02-14 1:28 pm Purchase | 13G | CLEARSIDE BIOMEDICAL INC CLSD | RTW INVESTMENTS LP | 3,750,107 9.11% | 2,408 (+0.06%) | View |
2019-12-04 4:40 pm Purchase | 13D | CLEARSIDE BIOMEDICAL INC CLSD | Hatteras Venture Advisors III LLC | 5,014,920 11.3% | 1,529,276 (+43.87%) | View |
2019-11-26 12:58 pm Purchase | 13G | CLEARSIDE BIOMEDICAL INC CLSD | WHITMORE BRADFORD T | 5,435,341 12.3% | 2,235,341 (+69.85%) | View |
2019-09-23 09:28 am Purchase | 13G | CLEARSIDE BIOMEDICAL INC CLSD | RTW INVESTMENTS LP | 3,747,699 9.93% | 3,747,699 (New Position) | View |
2019-07-17 5:24 pm Sale | 13D | CLEARSIDE BIOMEDICAL INC CLSD | Hatteras Venture Advisors III LLC | 3,485,644 9.3% | -141,889 (-3.91%) | View |
2019-05-10 1:40 pm Sale | 13G | CLEARSIDE BIOMEDICAL INC CLSD | BlackRock Inc. BLK | 1,823,591 4.9% | -79,197 (-4.16%) | View |